XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION - Summary of Reclassifications (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
segment
Mar. 31, 2022
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Number of operating segments | segment 3  
Total costs of sales $ 44,177 $ 36,681
Total gross profit 42,056 41,190
Product development 9,836 8,064
General and administrative 14,952 13,426
Operating Expenses 35,761 32,204
Previously Reported    
Total gross profit   39,815
Product development   7,101
General and administrative   13,014
Operating Expenses   30,829
Restatement Adjustment    
Total gross profit   719
Product development   306
General and administrative   412
Operating Expenses   718
As reclassified    
Total gross profit   40,534
Product development   7,407
General and administrative   13,426
Operating Expenses   31,547
Impact of operating expense allocations    
Total gross profit   657
Product development   657
General and administrative   0
Operating Expenses   657
RCM    
Total costs of sales 27,183 20,398
RCM | Previously Reported    
Total costs of sales   20,430
RCM | Restatement Adjustment    
Total costs of sales   (32)
RCM | As reclassified    
Total costs of sales   20,398
RCM | Impact of operating expense allocations    
Total costs of sales   0
EHR    
Total costs of sales $ 16,348 15,339
EHR | Previously Reported    
Total costs of sales   16,683
EHR | Restatement Adjustment    
Total costs of sales   (687)
EHR | As reclassified    
Total costs of sales   15,996
EHR | Impact of operating expense allocations    
Total costs of sales   $ (657)